Why 5-HT2C Agonists Could Be the Next Big Epilepsy Treatment Breakthrough | |
Epilepsy treatment challenges persist despite affecting over 70 million people worldwide. What's even more concerning is that approximately one-third of these individuals—around 23 million people—suffer from drug-resistant epilepsy (DRE), which significantly increases their risk of premature death and injuries. Despite decades of research and numerous epilepsy treatment drugs available on the market, many patients continue to experience seizures that drastically impact their quality of life. | |
Related Link: Click here to visit item owner's website (0 hit) | |
Target Prov.: Ontario Target City : Toronto Last Update : May 14, 2025 3:20 AM Number of Views: 51 | Item Owner : brightmindsbio Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |